{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:26:39Z","timestamp":1793363199537,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.ajkd.2013.10.042","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T01:15:28Z","timestamp":1386206128000},"page":"584-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Plasma PCSK9 in Nephrotic Syndrome and in Peritoneal Dialysis: A Cross-sectional Study"],"prefix":"10.1053","volume":"63","author":[{"given":"Kyubok","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2013.10.042_bib1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1046\/j.1523-1755.2003.00941.x","article-title":"Molecular mechanisms of lipid dysregulation in nephrotic syndrome (Nephrology Forum)","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.042_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2013.10.042_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.1991.190","article-title":"Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic range proteinuria","volume":"40","author":"Warwick","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0026-0495(90)90074-M","article-title":"Low-density lipoprotein metabolism in the nephrotic syndrome","volume":"39","author":"Warwick","year":"1990","journal-title":"Metabolism"},{"key":"10.1053\/j.ajkd.2013.10.042_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.1996.388","article-title":"Downregulation of hepatic LDL receptor expression in experimental nephrosis","volume":"50","author":"Vaziri","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1046\/j.1523-1755.2003.00911.x","article-title":"Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.CIR.0000136023.70841.0F","article-title":"Acyl-CoA cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, LCAT, SRB-1 and LDL receptor deficiencies in nephrotic syndrome","volume":"110","author":"Vaziri","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.042_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.metabol.2007.05.007","article-title":"Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome","volume":"56","author":"Kim","year":"2007","journal-title":"Metabolism"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.042_bib9","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ki.2012.244","article-title":"Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels","volume":"82","author":"Wang","year":"2012","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib10","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2013.10.042_bib11","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ajkd.2013.10.042_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/BJ20070664","article-title":"Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity","volume":"406","author":"Li","year":"2007","journal-title":"Biochem J"},{"key":"10.1053\/j.ajkd.2013.10.042_bib13","doi-asserted-by":"crossref","first-page":"20799","DOI":"10.1074\/jbc.C700095200","article-title":"Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells","volume":"282","author":"McNutt","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.ajkd.2013.10.042_bib14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.042_bib15","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.042_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","article-title":"Mechanisms of dyslipidemia of chronic renal failure","volume":"10","author":"Vaziri","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib17","doi-asserted-by":"crossref","unstructured":"Liu S, Vaziri ND. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome [published online ahead of print October 28, 2013]. Nephrol Dial Tranplant. http:\/\/dx.doi.org\/10.1093\/ndt\/gft439.","DOI":"10.1093\/ndt\/gft439"},{"key":"10.1053\/j.ajkd.2013.10.042_bib18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1373\/clinchem.2007.091280","article-title":"Serum proprotein convertase subtilisin kexin type9 is correlated directly with serum LDL cholesterol","volume":"53","author":"Alborn","year":"2007","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2013.10.042_bib19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1373\/clinchem.2007.099747","article-title":"Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment","volume":"54","author":"Lambert","year":"2008","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2013.10.042_bib20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1373\/clinchem.2009.128645","article-title":"Plasma proprotein convertase subtilisin\/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?","volume":"55","author":"Chan","year":"2009","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2013.10.042_bib21","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2011.12.043","article-title":"Plasma PCSK9 levels and clinical outcomes in the treating to new targets trial: a nested case-control study","volume":"59","author":"Huijgen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2013.10.042_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","article-title":"Sterol dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2","volume":"49","author":"Jeong","year":"2008","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2013.10.042_bib23","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2013.10.042_bib24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1046\/j.1523-1755.2002.00319.x","article-title":"Upregulation of acyl-coenzyme A: cholesterol acyltransferase (ACAT) in nephrotic syndrome","volume":"61","author":"Vaziri","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.042_bib25","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1074\/jbc.M508582200","article-title":"Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c","volume":"281","author":"Costet","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.ajkd.2013.10.042_bib26","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1194\/jlr.P009860","article-title":"Fasting reduces plasma proprotein convertase, subtilisin\/kexin type 9 and cholesterol biosynthesis in humans","volume":"51","author":"Browning","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2013.10.042_bib27","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/ATVBAHA.110.214130","article-title":"Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans","volume":"30","author":"Persson","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861301425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861301425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:15:49Z","timestamp":1759457749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861301425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S027263861301425X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.10.042","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma PCSK9 in Nephrotic Syndrome and in Peritoneal Dialysis: A Cross-sectional Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}